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Brain reward systemRecent research shows that the effects of oxytocin are more diverse than initially thought and that in some cases
oxytocin can directly inﬂuence the response to drugs and alcohol. Large individual differences in basal oxytocin
levels and reactivity of the oxytocin system exist. This paper will review the literature to explore how individual
differences in the oxytocin system arise and examine thehypothesis that thismaymediate someof the individual
differences in susceptibility to addiction and relapse.
Differences in the oxytocin system can be based on individual factors, e.g. genetic variation especially in the
oxytocin receptor, age or gender, or be the result of early environmental inﬂuences such as social experiences,
stress or trauma. The paper addresses the factors that cause individual differences in the oxytocin system and
the environmental factors that have been identiﬁed to induce long-term changes in the developing oxytocin
system during different life phases.
Individual differences in the oxytocin system can inﬂuence effects of drugs and alcohol directly or indirectly. The
oxytocin systemhas bidirectional interactionswith the stress-axis, autonomic nervous system, neurotransmitter
systems (e.g. dopamine, serotonin and GABA/glutamate) and the immune system. These systems are all impor-
tant, even vital, in different phases of addiction.
It is suggested that early life adversity can change the development of the oxytocin system and the way it modu-
lates other systems. This in turn couldminimise the negative feedback loops thatwould normally exist. Individuals
may showonlyminor differences inbehaviour and function unless subsequent stressors or drug use challenges the
system. It is postulated that at that time individual differences in oxytocin levels, reactivity of the system or inter-
actionswith other systems can inﬂuence general resilience, drug effects and the susceptibility to develop problem-
atic drug and alcohol use.
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Addiction is a major problemworldwide that directly and indirectly
affects a large percentage of the population. According to the United
States Substance Abuse and Mental Health Services Administration's
(SAMHSA's) National Survey on Drug Use and Health, 8.7% of US popu-
lation aged 12 or older received treatment for an illicit drug or alcohol
abuse problem in 2010 (22.1 million; SAMHSA, 2011). The majority
of these people sought help for alcohol dependence, with 15 million
people in treatment for alcohol dependence alone, while another
2.9 million were treated for dependence on both alcohol and illicit
drugs.
However, these statistics only represent a small portion of the peo-
ple that struggle with alcohol and drug use. There are large differences
among individuals in the capacity to manage alcohol and drug use,
which seem to be based on genetic variation, the environment and per-
sonal factors (Wichers et al., 2013). Some people respond strongly to
the rewarding effects of drugs, while others experience many side ef-
fects. Drugs can also fulﬁl different roles in someone's life; some people
may rely on alcohol to calm their anxiety, while others may only devel-
op a problem with its use in the context of a traumatic event (e.g. the
death of a loved one). Studies going back to the 1980's have shown
that oxytocin is able to affect drug effects and addiction processes
(Ibragimov et al., 1987; Kovács et al., 1985, 1998). Most current studies
focus on the effects of exogenous oxytocin on drug effects and relapse,
however, individual differences in the endogenous oxytocin might
explain some of the individual differences seen in susceptibility to
addiction. This paper will postulate that early adversity can inﬂu-
ence the developing oxytocin system and affect susceptibility to ad-
diction (Fig. 1). Special attention will be paid to potentially critical
periods when speciﬁc environmental inﬂuences may induce lifelong
changes.
This paperwill focus on the direct effects of the neuropeptide oxyto-
cin and the modulatory effects of oxytocin on several key systems thathave been implicated in the biology of addiction. The overlap between
the neurocircuitry for afﬁliative and drug-taking behaviour was de-
scribed by Insel (2003), focusing on the oxytocin, vasopressin and
mesolimbic dopamine system. The focus of the present review will be
even broader, also considering the interactive roles in addiction of neu-
rotransmitter systems, of the hypothalamic–pituitary–adrenal (HPA)
axis, the immune system and the effects on the central nervous system
(CNS) and behaviour. We will postulate that a well-regulated oxytocin
system can increase resilience and reduce the probability that an indi-
vidual will develop an addiction by both direct effects, and interactions
with other key systems.
The paper will provide an overview of several key biological systems
implicated in the biology of addiction, focussing on neurotransmitter
systems, HPA-system and immune system. It will then focus on provid-
ing an overview of the endogenous oxytocin system and importantly on
individual differences in the oxytocin system. Subsequently, the docu-
mented effects of exposure to environmental factors on the endogenous
oxytocin system are analysed for different life phases (prenatal, early
life, childhood, adolescence and adulthood) and possible outcomes are
discussed. The focus then shifts to the direct effects of oxytocin on
drug effects and addiction, and its ability to modulate key biological
systems implicated in the biology of addiction; special attention will
be paid to bidirectional interactionswith themesolimbic dopamine sys-
tem, HPA-axis, serotonin system, glia and peripheral immune system,
and Vagus Nerve. To conclude, a model for the possible involvement
of the endogenous oxytocin system in addiction is described and the
strengths and weaknesses of the theory are discussed.2. Addiction and individual differences
Addiction extends beyond using drugs often and in large quantities.
It is characterised by the development of tolerance and physical or
psychological dependence, as well as by increased time spent using or
Fig. 1. Suggestedmodel: individual factors and (early) environment shape the development of the oxytocin system affecting susceptibility to addiction. Substantial individual differences
exist in basal oxytocin levels and reactivity of the system. The endogenous oxytocin system changes and matures over time as part of normal development. This paper postulates that
individual factors and environmental factors inﬂuence the developing oxytocin system affecting oxytocin levels and responsiveness of the oxytocin system. Different factors are important
in different life phases, depicted as a biological predisposition, inﬂuences of early environmental factors and later environmental factors. When an individual is exposed to alcohol and
drugs in adolescence, these individual differences in the endogenous oxytocin system can affect reward seeking and drug use behaviour. It is postulated that for example drug use may
be more rewarding resulting in an escalation of use; an imbalance between natural and drug rewards could affect the attractiveness of excessive drug use; individuals may be more sus-
ceptible to stress-induced relapse to drug use.
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also is deﬁned by the inability to control the drug use or stop using,
and may include the experience of withdrawal on cessation of use.
Drug or alcohol abuse interferes with an individual's normal activities,
but may be continued despite its negative consequences. In addiction
research, different phases are described such as initiation, escalation,
dependence, withdrawal and relapse. Behavioural, psychological and
physiological measures are used to study these phases. Most experi-
mental research studying the development of dependence occurs in
animals, while research into the individual differences in susceptibility
to addiction in humans is based on epidemiological studies, brain imag-
ing and genetic studies. This paperwill draw on both animal and human
multidisciplinary data to elucidate the role of endogenous oxytocin in
addiction.
Animal research has focussed on individual differences within and
between strains of animals in drug seeking and development of addic-
tion. For example, behaviourally impulsive animals show increased
responses to drugs of abuse (Dalley et al., 2011; Marusich et al.,
2011; Yates et al., 2012). Environmental inﬂuences can also induce indi-
vidual differences in gene by environment interactions. For example
Ellenbroek et al. (2005) developed an animal model based on two
extremes within a normal rat population. They selected animals, with
distinctly different responses to a dopamine agonist (APO-SUS and
APO-UNSUS). These animals also responded differently in alcohol and
cocaine self-administration tests, while environmental stressors could
modify behaviours. Genetic differences were recorded, however the
authors concluded that a gene by environment effect was likely to be
the major contributor to differences in drug-taking behaviour.
Moffett et al. (2007) reviewed animal studies studying the long-
term differential effects of distinct maternal separation protocols;
these showed long-term effects of separation on subsequent alcohol
intake patterns. In mice, prenatal stress has also been associated with
a greater motivation for, and consumption of, alcohol in adulthood.Human studies have also focussed on gene and environment inter-
actions affectingdrug abuse and addiction. As one example, longitudinal
data from epidemiological studies indicate that experiencing maltreat-
ment and cumulative stressful life events prior to puberty, and particu-
larly in the ﬁrst few years of life, were associated with an early onset
of problem drinking in adolescence and with an increased likelihood
of alcohol and drug dependence in early adulthood (Enoch et al., 2010).
Recent developments in genetic research and imaging have ad-
vanced the capacity to study the biology of human addiction. Twin
studies have shown that both shared environment (for example,
socio-economic factors) and genetic factors have a strong inﬂuence on
the initiation of drug use (Agrawal and Lynskey, 2008; Munafò and
Johnstone, 2008; Verweij et al., 2010). Genes implicated in stress, anxi-
ety, attention, learning and memory and reward processing have been
the recent focus in addiction research. Increased impulsivity and atten-
tion deﬁcit hyperactivity disorder (Chang et al., 2012) is also associated
with an increased likelihood of addiction, possibly because of a ten-
dency toward early experimentation with drugs or alcohol. Major life
events or traumas may also increase the vulnerability to develop drug
dependence. Among the factors that have been implicated in addiction
are sensitivity to reward (for example, polymorphisms in the dopamine
receptor), differences in enzyme activity (for example, alcohol metabo-
lism) and social factors (such as peer and parental attitudes). Neurobio-
logical differences underlying severity of craving and responsiveness to
cue- or stress-induced relapse strongly affect how easily people quit
smoking. Addiction is a complex disease regulated by a number of
genes. The main emphasis in recent years has been on the role of gene
by environment interactions (Enoch, 2011; Enoch et al., 2010) and on
the effects of polymorphisms in genetic pathways (Reimers et al.,
2012) that are involved in the neurobiology of addiction. One step
further would be to examine epigenetic changes; for example, due to
oxygen deprivation during birth or continued use of drugs of abuse
which may have epigenetic consequences, which in turn would alter
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and Nestler, 2008), with potential consequences, for example, for
sustained drug dependence.
Advances in a diverse range of imaging techniques have increased
our understanding of brain areas involved in drug effects and in re-
sponses to associated cues. Thesemethods have permitted visualisation
of differences in responses to the environment and decision making
tasks that are important in understanding the underlying biology of
addiction (reviewed Parvaz et al., 2011; Volkow et al., 2012). Another
recent area of research combines neural imaging with an analysis of
genetic and environmental factors. Thus it becomes possible to examine
individual variability in reinforcement behaviour in the context of indi-
vidual differences in neural activation (Loth et al., 2011).
3. Biology of addiction: identifying the major players
Addiction is a complex disorder; the biological basis of addiction
mirrors this complexity. Studying addiction goes beyond examining di-
rect effects of a drug and includes: a focus onmemory of the experience
and setting associated with drug use; decisionmaking such as choosing
between short and long-term gain; loss of control; identifying triggers
for use, and so forth. It is likely that we do not yet have a full overview
of the systems that are involved or how they inﬂuence each other.
Although drugs exert their effects via different receptor systems, several
brain regions are involved in drug abuse in general. Brain regions that
are central to drug reward are part of the mesolimbic dopamine path-
way, including the nucleus accumbens (NAcc) and the ventral tegmen-
tal area (VTA). These regions extend to the prefrontal cortex (PFC),
which is critical for executive functioning and decisions concerning
drug use. The dopamine reward pathway seems to be central in robust
drug reward. However, recent publications providing a broader per-
spective on drug reward, suggest non-dopaminergic mechanisms of
reward as well (Ikemoto, 2010; Volkow et al., 2011). The limbic system
(including the VTA, NAcc and hippocampus) as a whole is important in
emotion, drive, and memory processes that affect addiction. The HPA-
axis is also a player that inﬂuences continued drug use, withdrawal
and relapse (Koob, 2008).
The role of major brain regions in speciﬁc brain processes related to
addiction is reviewed elsewhere (Parvaz et al., 2011). The systems listed
below are of particular importance as they play an important role in ad-
diction and they are inﬂuenced by the oxytocin system. However, this
list is not comprehensive, covering only a subset of factors that have
been implicated in addiction.
3.1. Neurotransmitters
Existing research has mainly focussed on the role of neurotransmit-
ter systems in drug effects and the development of addiction. Different
drugs act on different neurotransmitter systems, but nearly all drugs
of abuse eventually result in an increase in dopamine in themesolimbic
dopamine system reward pathway (Pierce and Kumaresan, 2006).
Neurotransmitter systems that are key to drug effects are the dopamine
system (for example, stimulants and MDMA), opioid system (heroin,
codeine and alcohol), serotonin (for example,MDMAandhallucinogens),
GABA and glutamate (for example, alcohol and benzodiazepines), and
the cannabinoid system (cannabis) (Parolaro et al., 2005). Beyond their
role in direct drug effects, many of these systems seem to be involved
in susceptibility to the development of addictions (Buisman-Pijlman
et al., 2009; Maldonado et al., 2006; Mechoulam and Parker, 2013;
Parolaro et al., 2005).
3.2. Stress and the hypothalamic–pituitary–adrenal (HPA) axis
Stress can increase vulnerability to drug addiction (see introduction)
and trigger relapse to alcohol and drug use after a period of abstinence
(Shalev et al., 2010). Sinha et al. (2011) provide a good overview ofthe role stress can play in relapse and how stress can trigger strong
craving. Because users often continue drug use to avoid withdrawal
the negative reinforcement of drugs can become more important than
the positive reinforcement effects. Several studies looking at continued
drug use and withdrawal have focussed on the role of corticotropin
releasing factor (CRF; Koob, 2008); CRF is an central factor in the regu-
lation of theHPA-axis in response to stress, and CRF has been implicated
in the negative reinforcing effects of drugs after prolonged drug use
(Koob, 2008).
3.3. Immune system
In recent years, a new player has been implicated in the neuro-
biology of addiction: the immune system. The immune system can
alter neuronal signalling in the brain with consequences for behaviour
and cognition. A large part of the brain consists of supportive, non-
neuronal tissue such as glia. This “supportive” tissue also regulates
brain function. Oliet et al. (2008) demonstrated that glia processes
were able to affect neuronal signalling of glutamate and GABA signal-
ling. Additionally, cytokines are immune modulators, involved in creat-
ing a pro-inﬂammatory state that can inﬂuence how the body responds
to subsequent challenges (illness or stressors). A “primed” immune
system, in which the body is in a pro-inﬂammatory phase, seems to
increase the risk for several psychopathologies such as addiction, de-
pression and pain (Dantzer et al., 2008). For example, animal studies
have shown that postnatal stress can cause a pro-inﬂammatory phase,
which later affects drug withdrawal in mice (Schwarz et al., 2011).
Changes in the immune system are capable of increasing direct drug
rewards (Hutchinson et al., 2012). Althoughwe do not fully understand
the mechanism through which the immune system affects addiction
behaviour, it interacts with several key systems (like dopamine and
HPA-axis) that are central to addiction.
3.4. Oxytocin
Neuropeptides have been of interest to addiction research for sev-
eral decades but have not taken centre stage. In the 1980s, the effect
of oxytocin administration became a focus of preclinical addiction
research (Kovács et al., 1998; Sarnyai and Kovacs, this issue). Vasopres-
sin is a related nonapeptide which is produced and released from some
of the same brain regions as oxytocin, butwith different functions in the
body (Neumann and Landgraf, 2012). As oxytocin and vasopressin have
afﬁnity for each other's receptors, ﬁndings on vasopressin are alsomen-
tioned here at crucial points.
Several clinical studies have investigated the effect of intranasal oxy-
tocin in relapse to addiction (clinicaltrials.gov), although available data
in humans are generally preliminary, there are indications that exoge-
nous oxytocin may have beneﬁts in addiction (Pedersen et al., 2012).
However, the current paper will focus on the evidence for a role in ad-
diction of the endogenous oxytocin system. Before the role of oxytocin
in addiction is described, we will provide an overview of the endoge-
nous oxytocin systemand factors affecting individual differences in oxy-
tocin level and receptors.
4. Endogenous oxytocin system
4.1. Oxytocin synthesis
Oxytocin is a neuropeptide consisting of 9 amino acids. It was func-
tionally identiﬁed in 1906 by Sir Henry Dale, and described chemically
in the 1950s byVincentDuVigneaud (Lee et al., 2009). Oxytocin synthe-
sis in the central nervous system (CNS) primarily takes place in the
paraventricular nucleus (PVN) and the supraoptic nucleus (SON) of
the hypothalamus. Themajority of oxytocin is transported to the poste-
rior pituitary where it is released into the bloodstream, with effects on
tissues throughout the body (Leng et al., 2011; Quirin et al., 2011).
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cluding the uterine epithelium, ovary, testis, vascular endothelium cells
and heart (Nishimori et al., 2008).
4.2. Regulation of release
Release of oxytocin by the posterior pituitary into the blood stream
is triggered by vaginocervical and nipple stimulation (Nishimori et al.,
2008). However, oxytocin alsomay be released by positive social stimuli
including close physical contact in a safe environment; exposure to in-
fants and orgasm; in addition, noxious stimuli; conditioned fear; novel
environments (Burri et al., 2008; Carter, 19921998; Feldman et al.,
2012; Kenkel et al., 2012; Neumann and Landgraf, 2012; Opacka-Juffry
and Mohiyeddini, 2012; Pournajaﬁ-Nazarloo et al., 2013; Sasayama
et al., 2012; Uvnäs-Moberg, 1998).
A variety of studies in healthy humans have reported large and reli-
able individual variations in plasma levels of oxytocin. For example,
Opacka-Juffry and Mohiyeddini (2012) using enzyme-immunoassay
in unextracted samples report plasma (venous blood) oxytocin con-
centrations in men, ranging from 79 to 1198 pg/ml, with an average
of 378 pg/ml. Similar ranges are seen in studies by Feldman et al.
(2012); Weisman et al. (2013) and in Gouin et al. (2010), with even
more individual variation seen in clinical populations such as Williams
Syndrome (Dai et al., 2012). Comparisons across studies can be difﬁcult
since values may differ depending on the analysis techniques that was
used (Szeto et al., 2011). However, recent evidence from mass spec-
trometry revealed that oxytocin (as well as vasopressin) levels can
reach the ng/ml range in plasma. These peptides are sequestered by
binding to plasma proteins, possibly delivering these hormones to tis-
sues as needed, with beneﬁcial consequences especially in the face of
challenge (Martin and Carter, 2013).
Relative amounts of gene expression for oxytocin and vasopressin
also support the hypothesis that these peptides are available in great
abundance (Gautvik et al., 1996). In the CNS these peptides can be re-
leased from both synapses and axons in the brain and can diffuse into
other brain areas (Borrow and Cameron, 2012; Campbell et al., 2009;
Ishak et al., 2011). Cells originating in the PVN have speciﬁc pathways
which efﬁciently deliver oxytocin to other structures in thebrain includ-
ing the amygdala, bed nucleus of the stria terminalis (BNST), lateral sep-
tum, hippocampus and NAcc (Stoop, 2012).
Several studies demonstrate that oxytocin is more readily released
in situations where a social component is present (Feldman et al.,
2012). For example, oxytocin levels in calves are increased by suckling
from their mother, but not when drinking the same milk from a bucket
(Lupoli et al., 2001). Additionally, oxytocin can also reduce pain or HPA-
axis reactivity after stress (Dabrowska et al., 2011), but only when a
social partner is present. This highlights the importance of social inter-
action in the release and actions of oxytocin.
4.3. Central and peripheral levels
Oxytocin can be released in the periphery and centrally, as described
above. Oxytocin released by peripheral organs or by the posterior
pituitary does not readily cross the blood–brain barrier (BBB), with
only 1–2% crossing (Opacka-Juffry and Mohiyeddini, 2012). Veening
and Olivier (2013) discuss possible other ways in which oxytocin can
pass from the periphery to the brain and back. McEwen (2004) reports
that oxytocin seems to be transported by a saturable carrier; disappear-
ance rate from the brain for 125I-oxytocin was 19.1 min. Oxytocin may
be able to cross the foetal, or a damaged BBB,more readily. For example,
addiction may induce leakage of peptide from the blood to the cerebro-
spinal ﬂuid (CSF; Kovács et al., 1998; Nishimori et al., 2008). BBBperme-
ability can also be affected by, for example, hypertension, stress or
disease (Churchland and Winkielman, 2012).
It is unclear what percentage of peripherally administered oxytocin
reaches oxytocin receptors in the brain. However, research datingback to the 1980s shows that a signiﬁcant amount of peripherally
injected oxytocin does reach the brain (Carson et al., 2010a, 2010b;
Kovács and Telegdy, 1988; Neumann et al., 2013; Van Ree and De
Wied, 1977). A recent review by Veening and Olivier (2013) sheds
light on our current (limited) understanding of how intranasal oxytocin
reaches the brain. However, oxytocin levels measured in the blood may
not directly represent concentrations in speciﬁc brain regions (Opacka-
Juffry andMohiyeddini, 2012). However, as oxytocin is released by the
hypothalamus into the blood, measurements of peripheral oxytocin
may serve as a relative approximation of hypothalamic hormone
production.
4.4. Receptor
Until now, only one oxytocin receptor has been identiﬁed: the
oxytocin receptor (OXTR). It is widespread in the brain and body in a
sex-and species-speciﬁc manner (Georgescu et al., 2003; Lee et al.,
2009). OXTR is expressed in themammary gland, uterinemyometrium,
adipose precursor cells, gastrointestinal tract, cardiac muscle of the
heart, and vascular endothelium layer (Gimpl and Fahrenholz, 2001;
Ohlsson et al., 2006; Nishimori et al., 2008). A high density of OXTR
can be found in brain regions involved in regulatingmood, social behav-
iour and addictive processes (Burri et al., 2008; Sarnyai, 2011), such as
the cortex, hippocampus, VTA, NAcc, hypothalamus, ventral pallidum,
limbic system, basal ganglia, medial preoptic area, olfactory bulbs,
(central) amygdala and brain stem (Gimpl and Fahrenholz, 2001).
The OXTR receptors in the periphery and central nervous system are
considered to be the same (Nishimori et al., 2008).
The OXTR is a member of the G-protein coupled receptor family
and is 388 amino acids in length (Nishimori et al., 2008). Activation of
OXTR by the binding of OXT to its outer membrane domain activates
G-protein alpha subunit, phospholipase C and protein kinase C, and
ﬁnally activates numerous cellular proteins and accelerates the outﬂow
of Ca++ from the endoplasmic reticulum, leading to several down-
stream cellular responses. Interestingly, differences in downstream
processes after activation of the receptor in different sites in the body
seem to facilitate diversity in functions of oxytocin. Although oxytocin
binds only to one type of receptor, the receptor couples to two different
G proteins, Gq/11 at its proximal portion of the C-terminus and to Gi/o
(Hoare et al., 1999). Since then papers have explored how these differ-
ent signalling pathways could facilitate the diversity in functions that
oxytocin displays (Chini and Fanelli, 2000; Devost et al., 2008). Gimpl
et al., 2008; Rimoldi et al., 2003).
Additionally, dramatic up- and down-regulation takes place in spe-
ciﬁc periods of life (for example around parturition; Devost et al.,
2008). The dynamic changes in expression of the oxytocin receptor,
and the different downstream processes in speciﬁc regions after activa-
tion, offer a source for individual variability.
Oxytocin also has afﬁnity for the vasopressin receptor and vice versa
(Ohlsson et al., 2006); three vasopressin receptor subtypes have been
identiﬁed V1a, V1b and V2. The maximum effect of oxytocin and vaso-
pressin on contractilemovement in the uterus is comparable, but oxyto-
cin is more potent in exerting its effect (Nishimori et al., 2008). Several
well-known agonists for the oxytocin receptor also have high afﬁnity for
the vasopressin receptor 1a (AVPRV1a; Lee et al., 2009).
Lemaire et al. (2002) suggest that the oxytocin and vasopressin
AVPRV1a receptors (and not AVPRV1b) are the predominant receptor
subtypes in rat brain and spinal cord; distribution is receptor speciﬁc.
Comprehensive information on speciﬁc afﬁnity and efﬁcacy of the dif-
ferent oxytocin and vasopressin receptors can be found in Chini et al.
(2008).
4.5. Functions of oxytocin
Oxytocin is implicated in the regulation of a wide range of behav-
iours and physiological responses. Oxytocin is well known for its role
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and Neumann, 2007). However, oxytocin is also thought to increase
interpersonal trust, reduce anxiety, reduce stress responses, reduce im-
mune and inﬂammatory response, alter memory and information pro-
cessing, and reduce pain (Bartz et al., 2011; Baskerville and Douglas,
2010; Carter, 1998; Lemaire et al., 2002; McGregor and Bowen, 2012;
Sarnyai and Kovács, 1994; Smith and Wang, 2012; Tops et al., 2012;
Uvnäs-Moberg, 1998; Veenema and Neumann 2008; Waldherr and
Neumann, 2007; Weisman et al., 2012). However, it is important to
note that not all subjects respond positively to oxytocin when given
exogenously (Bartz et al., 2011).
The aim of this paper is to investigate the role of oxytocin in drug
effects and addiction, which will be discussed extensively in Section 6.
5. Individual differences in the endogenous oxytocin system
Oxytocin seems to mediate a large range of effects, but research
shows that individual differences in oxytocin levels are quite large.
Human research shows large differences not only in basal levels of oxy-
tocin, but also in response to challenges which have been correlated
with various behavioural differences (Gouin et al., 2010; Weisman
et al., 2012).
Additionally, individual-, species- and sex -speciﬁc differences exist
in the abundance of central oxytocin receptors (Carter, 2007; Phelps
et al., 2010).
The following differences in the oxytocin system could have func-
tional outcomes that translate into behavioural differences: expression
of oxytocin and its receptor; number, location and sensitivity of recep-
tors; and connectivity with other systems.
Only limited research has been conducted on the origin of these in-
dividual differences. Individual differences can be based on age, gender
and genetic differences. Large differences also seem to exist between
species in the distributions of oxytocin (and vasopressin) receptors
that appear to correlate with the sociality of these animals (Shapiro
and Insel, 1989; Witt et al., 1992).
At least some differences are induced by the environment, such as
early experiences and other environmental factors for example drug
use (Bales et al., 2011). Since the oxytocin system continues to develop
during the postnatal and adolescent periods in rodents (Nylander
and Roman, 2012) and humans (Bales and Perkeybile, 2012), the fol-
lowing factors might be able to contribute to the observed individual
differences: early life adversity; parenting; social experiences; gene x
environment interactions; differential susceptibility; epigenetic factors;
and drug-induced changes.
The following sections will discuss the individual differences in the
endogenous oxytocin that have been observed based on individual
and environmental factors. Lastly, the paper will report on the possible
effect of the age at which exposure to these environmental factors took
place.
5.1. Individual factors
5.1.1. Gender differences
In general, sex differences are not seen in peripheral blood levels
of oxytocin. However, sex steroids can affect both oxytocin synthesis
and receptors (Gimpl and Fahrenholz, 2001). Looking at the role of
sex hormones, we know that oxytocin receptor expression is affected
by oestrogen (Young et al., 1997). Interestingly, neonatal oxytocin can
also alter oestrogen receptor alpha expression and oestrogen sensitivity
in female rats (Perry et al., 2009).
Additionally, oxytocin responses to stress may be sexually dimor-
phic, especially during early life as shown in animal studies (Bales
et al., 2011). Carter et al. (Heim et al., 2009) reviewed gender-speciﬁc
differences in the effects of prenatal and early life stress on the oxytocin
and vasopressin receptors. Studies from animals suggest a particularly
important role for oxytocin and changes in that pathway in females,while vasopressin pathways, especially in the central nervous system,
may be of special relevance to males.
The role of sex steroids in gender differences, and in oxytocin recep-
tor binding and expression, could also be at the basis of disparities
reported in human studies (Opacka-Juffry and Mohiyeddini, 2012).
5.1.2. Genetic differences
Individual differences in the oxytocin gene or receptor can cause
changes in basal levels, or responses after stimulation of the receptor.
Polymorphisms in the oxytocin gene and the oxytocin receptor gene
have been linked primarily to differences in stress reactivity and empa-
thy, changed perception of social cues, aggression, attachment, and par-
enting (Ebstein et al., 2012; Feldman et al., 2012; Malik et al., 2012;
Rodrigues et al., 2009). Importantly, Tost et al. (2010) demonstrated
using neuroimaging techniques structural and functional alterations in
the brains of (human) male and female carriers of the OXTR risk allele
(focusing on rs53576). They observed that structural alterations in key
oxytocinergic regions emerged, particularly in the hypothalamus. Im-
portantly, these neural characteristics predicted lower levels of reward
dependence, speciﬁcally in male risk allele carriers. They identiﬁed a
sex-dependent difference that is of interest for the current paper. Addi-
tionally, oxytocin gene polymorphisms have also been demonstrated to
inﬂuence dopamine function in humans (Love et al., 2012). Recent
unpublished research by this group also shows a change in alcohol use
in adolescents with a variation in the oxytocin gene (Glaser et al.,
2013). A variation in this gene (rs4813625) explains individual varia-
tion in adolescent alcohol drinking, and imaging studies suggest that
this effect is mediated by an interaction with the dopamine system
and is sex dependent.
Interestingly, two OXTR polymorphisms (rs4564970 and rs1488467)
were shown to moderate alcohol induced aggressive behaviour in adult
men (Johansson et al., 2012a, 2012b).
Williams Syndrome is an illness that has recently been linked to an
overproduction of oxytocin and vasopressin in response to speciﬁc
stimuli such as music (Dai et al., 2012) based on a genetic mutation.
People with this syndrome show developmental delays and mental re-
tardation, while being overly friendly and trusting. Some individuals
with this condition produce very high levels of oxytocin in response to
either music or an aversive stimulus. In Williams Syndrome, oxytocin
was negatively correlated with adaptive social behaviours. However,
the status of the oxytocin receptor needs to be studied before drawing
conclusions about the implications of these ﬁndings, since prolonged
exposure to high levels of oxytocin might down-regulate the receptor.
No papers are available on alcohol and drug use in people with this syn-
drome, but it would be interesting to know if they have reduced vulner-
abilities to addiction.
Oxytocin knockout animals show reduced ﬂexibility in behaviour
(Sala et al., 2011). Amico et al. (2005) showed that adult knockout
mice showed increased levels of sucrose intake when tested in a two
bottle-choice paradigm; this difference was sustained over several test-
ing day. They replicated this ﬁnding using the non-caloric saccharin
(Billings et al., 2006) and even showed that stress did not diminish
this increase. These ﬁndings seem to show that the endogenous oxyto-
cin system is involved in limiting intake of new and familiar palatable
substances and that stress-induced anhedonia is disturbed in knockout
mice.
Interestingly, McGregor and Bowen (2012) postulated that extreme
dopamine stimulation without oxytocin stimulation results in object-
oriented behaviour such as that seen in autism (with a disproportionally
high prevalence in males) and addiction. Hollander et al. (2003) dem-
onstrated that oxytocin levels were reduced in children with autism,
and that disturbances in repetitive behaviour could be normalised with
(intranasal) oxytocin (Hollander et al., 2003;Modahl et al., 1998). Gener-
alities regarding endogenous oxytocin in autism may be premature,
since studies are rare and the origins of these differences remain to be
determined. The literature regarding the role of oxytocin in disorders
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diagnostic variation or age.
5.1.3. Age and development of the oxytocin system
The endogenous oxytocin system starts to develop in utero and
continues to develop during the postnatal period and adolescence in ro-
dents (Nylander and Roman, 2012) and humans (Bales and Perkeybile,
2012). Detailed information on the development of the oxytocin system
is mainly derived from animal studies using rats and prairie voles; for a
review see Bales and Perkeybile (2012). OXTR in the rat brain is present
during the entire period of development, whilst prairie voles show tran-
sient expression and reorganisation (Bales and Perkeybile, 2012). Rat
studies show that receptor afﬁnity of the oxytocin receptor does not
seem to change during development, with infant receptors being func-
tional already. However, OXTR density changes with age in rats and is
also inﬂuenced by maternal separation (Lukas et al., 2010). Most nota-
bly, OXTR binding density in the caudate putamen showed a 2-fold de-
crease while OXTR binding in the ventromedial hypothalamus showed
a 4-fold increase with age. The functional signiﬁcance of regional differ-
ences in the OXTR remains largely unexplored.
5.2. Environmental factors and life phase
The development and functioning of the oxytocin system seems to
be sensitive to external inﬂuences such as social environment, stress
and illness. As the oxytocin continues to develop after birth (5.1.3),
timing of these external inﬂuences can affect the ﬁnal outcome. Data
also show that the adult oxytocin system retains plasticity, which
makes it responsive to external stimuli and naturally-occurring chang-
ing demands in life such as around lactation and parturition.
The following section will discuss the inﬂuences that can alter the
endogenous oxytocin system prenatally, in infancy, adolescence or
adulthood.
5.2.1. Prenatal period: stress and drug exposure
Factors affecting oxytocin system during this period mainly relate to
the affect of prenatal stress and drug exposure.
Exposing pregnant rat dams to unpredictable stressors during the
lastweek of gestation resulted in changed social behaviour (reduced so-
cial drive) and reduced levels of oxytocin mRNA in the paraventricular
nucleus, and increased oxytocin receptor binding in the central amyg-
dala in male offspring (Lee et al., 2007). De Souza et al. (2013), also
showed the long-term effects of prenatal stress exposure (restraint) in
the same period on social behaviour, but focussed on the number of
oxytocin neurons in the PVN and SON in adult rats. Animals were
cross-fostered to prenatally stress or not-prenatally stressed mothers.
Only the combination of being exposed to prenatal stress and being
raised by a prenatally-stressed rat dam resulted in adult male offspring
with a decreased number of OXT-positive magnocellular neurons,
VP-positive magnocellular and parvocellular neurons of the PVN. No
changes were shown in the OXT and VP cellular composition of the
SON nucleus. Animals showed increased anxiety-like behaviour and
aggressiveness.
Prenatal alcohol and drug exposure was able to alter OXT levels and
receptor binding in speciﬁc regions. Johns et al. (1998) clearly demon-
strated that gestational cocaine exposure causes long-term decreases
in OXT levels in hippocampus, hypothalamus and preoptic area.
Williams et al. (2009) also showed that the combination of prenatal
alcohol and nicotine exposure affects oxytocin receptor binding, ethanol
consumption and preference. Oxytocin receptor binding in the NAcc
and hippocampus was increased in prenatally-exposed adult males
only. Prenatal exposure to both of these drugs sex-speciﬁcally decreased
ethanol preference behaviour in offspring, unlike reports for either drug
separately; this effect was different in different age groups. For a com-
prehensive review of the distinction between the impact of gestationalcocaine exposure and the effect of cocaine on parental behaviour in rat
dams please refer to Williams and Johns (2014).
5.2.2. Infancy and early life: maternal separation and attachment
Extensive research focuses on the long-term effects of early life ad-
versity and social environment on the oxytocin system, although most
studies use animal research. Maternal and social interactions during
the neonatal period organize the subsequent expression of behaviour
by altering sensitivity to neuropeptides including oxytocin and vaso-
pressin (Bales et al., 2011; Cushing and Kramer, 2005).
Furthermore, in humans the oxytocin system seems to be sensitive
to positive early social experiences and negative experiences such as
separation (Feldman et al., 2012). A positive effect of the environment
on oxytocin levels has been reported in infants who had experienced
high affect parent-infant synchrony (i.e. monitoring and responding).
These infants showed increased oxytocin saliva measures compared to
infants reared in the presence of low affect synchrony (Feldman et al.,
2010b); these children also showed more social competence. Tops
et al. (2014-in this issue) explore the effect of attachment and oxytocin
on engagement of cortical loops, exploringwhether oxytocin is involved
in the overlapping mechanisms of stable attachment-formation and
stress-coping.
Looking at the impact of social deprivation, Wismer Fries et al.
(2005) reported that the oxytocin system was affected in children
who had been exposed to extremely adverse early upbringing directly
after birth. Children who were raised in institutions in Romania before
they were adopted into a family showed altered oxytocin reactivity
when tested at the age of 4. Basal urine oxytocin levels were the same,
but adopted children did not show an increase in oxytocin levels during
physical contactwith their adopted parent or a stranger. Control children
raised in family environment did show an increase, but only when con-
tact was with their own parent. [Note: Although concerns have been
raised about the validity of themeasures and analysis in this experiment
(Anderson, 2006), the differences were based on within-subject mea-
surements supporting the internal validity of this study].
Early life stress (based on questionnaires) was linked to lower oxyto-
cin levels in healthy adult males; the effect was moderated by trait anx-
iety (Opacka-Juffry andMohiyeddini, 2012). Early parental separation in
humans was also associated with decreased salivary cortisol excretion
in response to intranasal oxytocin in young males (Meinlschmidt and
Heim, 2007).
Although studies of mechanism are relatively rare in humans, more
detailed information is available fromanimal research. Veenema (2012)
provide a good review of the effects of early-life manipulations in ro-
dents on the distribution of oxytocin and vasopressin receptors and on
their expression. In general animal models examine the effects of both
deprived and enriched early environments, and these show that differ-
ences in the quality of the early social environment are associated with
brain region-speciﬁc alterations in oxytocin and vasopressin expression,
and oxytocin receptor and vasopressin 1a receptor binding. However,
apparently small differences in early experience, such as a single han-
dling experience in early life possibly mediated by maternal behaviour,
can have profound and lasting consequences for later behaviour in the
offspring (Bales et al., 2011).
Maternal separation in rodents is a commonly-usedmodel to inves-
tigate postnatal stress, although differences in, for example, separation
duration can affect outcome. Nylander and Roman (2012) analysed
the effect of early life stress on oxytocin and alcohol drinking in animals.
Altered levels of oxytocin were observed in speciﬁc brain regions
(e.g. hypothalamus, pituitary and amygdala), however, this change
was not linked to changes in ethanol consumption in male rats
(Oreland et al., 2010).
Lukas et al. (2010) speciﬁcally investigated the effect of maternal
separation on OXTR and AVPRV1a in juvenile, adolescent and adult
rats. They found that maternal separation (3 h daily, PND 1–14) caused
robust age-related changes in OXTR and AVPRV1A binding in several
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shift in OXTR and AVPRV1A. OXTR binding was signiﬁcantly lower in
the agranular cortex (at juvenile and adolescent age), the lateral septum
(at adult age) and the caudate putamen (at adult age), but higher in the
medial preoptic area (at adolescent age) and ventromedial hypothala-
mus (at adult age) after exposure to MS (Lukas et al., 2010).
Ahern and Young (Heim et al., 2009) reported that parenting condi-
tions in rats affected oxytocin content and dorsal raphe CRF2 densities
in a sex-dependent manner; both measures were correlated with lick-
ing and grooming experienced during the ﬁrst 10 days of life. Parenting
conditions did not inﬂuence neuropeptide receptor densities in the ven-
tral forebrain (Ahern and Young, 2009).
Intergenerational transmission of individual differences in stress-
reactivity, possibly mediated in part by changes in oxytocin or its re-
ceptor, are likely candidates for some of the lasting effects of early
experience (Bales et al., 2011). Early life experiences exert gender-
dependent effects on the oxytocin and vasopressin systems, and stress
reactivity (Carter et al., 2009), which are mediated through changes in
expression of their central receptors.
Early social experiences may also induce epigenetic changes in the
gene for the oxytocin receptor (Connelly, unpublished data). In rats
maternal stimulation inﬂuences the maternal behaviour of female
offspring, which appears to be related to OXTR gene expression
(Champagne, 2008).
Epigenetic changes to the OXTR can also affect behaviour. Kumsta
et al. (2013) reviewed the effects and causes of oxytocin receptor gene
(OXTR) promoter methylation suggesting that psychosocial stress
exposure might dynamically regulate OXTR in this manner to cause
life-long changes in behaviour. Brüne (2012) discussed the impact of
epigenetic changes but from an evolutionary perspective, emphasising
the view that changes in theOXTRmight not cause increased vulnerabil-
ity to psychiatric disorders but differential susceptibility to the (early)
environment.
5.2.3. Childhood: stress, trauma and illness
Basal blood levels of oxytocin were reduced after childhood (but not
adolescent) stress in a sample of healthy males (Opacka-Juffry and
Mohiyeddini, 2012),while Heim et al. (2009) showed lower basal levels
in the CSF of women who experienced child abuse (emotional abuse
showed strongest effect). Reactivity of the oxytocin systemwas changed
in response to the Trier social stress test in a sample of childhood cancer
survivors compared to controls and people who had been sexually
abused (Pierrehumbert et al., 2010). Although the sample in this study
was not matched for age or socio-economic status, effects were detected
when the analysis corrected for these.
A recent paper by Branchi et al. (2012), demonstrated a develop-
mental role for peer interactions in the nest of rat pups. Individuals ex-
posed to high levels of peer interactions in the nest showed enhanced
adult afﬁliative behaviour and enhanced oxytocin receptor levels in
selected nuclei of the amygdala as measured using autoradiography.
5.2.4. Adolescence: experiences and drugs of abuse
In comparison to the large literature on early life, limited research
has focussed on factors inﬂuencing the oxytocin system during adoles-
cence. However, it is likely that this period marks a period of change
in the oxytocin system based on the fact that the oxytocin interacts
with so many systems that are either still developing during adoles-
cence (for example, PFC) or that are experiencing a critical phase during
adolescence (for example HPA axis; Tops et al., 2014-in this issue). It is
likely that social experiences are able cause long-lasting effects. As de-
tailed below, exposure to speciﬁc stimulants seems to induce transient
increases in oxytocin (Dumont et al., 2009;Wolff et al., 2006). However,
as Bowen et al. (2011) have shown in rats, a single administration of
oxytocin during adolescence can have effects on behaviours such as
alcohol drinking in adulthood. The mechanisms for such lasting effects
of oxytocin exposure in adolescence remain to be explored. However,adolescent social experiences, such as peer interactions, that hold the
potential to release endogenous oxytocin, also might have epigenetic
consequences, possibly by sensitizing oxytocin pathways to respond
more efﬁciently to oxytocin in adulthood.
In general, the existing literature suggests that social experience in
early life can have life-long consequences for subsequent behaviour
and emotional regulation. There also is increasing evidence that at alter-
ations in oxytocin pathways, including the oxytocin and vasopressin
peptides, and their receptors, may mediate these effects, possibly help-
ing to account for individual differences in the vulnerability to substance
abuse and addiction.
5.2.5. Adulthood: reproductive behaviour, stress, drugs of abuse
Factors reported to inﬂuence the adult oxytocin system are, for ex-
ample, strong natural triggers affecting homeostasis, stress and drugs
of abuse. Even in adulthood, changes in oxytocin pathways can have
profound and long-lasting consequences for behaviour.
For example, early research from Theodosis et al. (1986) showed
that the adult nervous system can undergo signiﬁcant experience-
related structural changes throughout life. They showed that intra-
cerebroventricular infusion of oxytocin, mimicking central release,
induced neuronal-glial and synaptic changes in the SON similar to
those detected under physiological stimulation. In 2010, Oliet and
Bonfardin demonstrated anatomical plasticity in the SON of the hypo-
thalamus during lactation, parturition and chronic dehydration. The
structural plasticity of the hypothalamic magnocellular nuclei includes
changes in neuron–glial interactions as well as changes in synaptic
and extrasynaptic transmission of oxytocin and glutamate neurons.
Additionally reproductive behaviour across the estrous cycle in female
rats is inﬂuenced by dendritic remodelling in oxytocin neurons in the
hypothalamic ventromedial nucleus (Ferri and Flanagan-Cato, 2012).
Stress is a natural trigger for oxytocin release, but a study by
Unternaehrer et al. (2012) showed that even an experimental psycho-
logical stress situationwas capable of causing alterations inmethylation
of the OXTR in humans. A Trier social stress test was capable of tempo-
rarily producing small but signiﬁcant alterations inmethylation of OXTR
in mononuclear blood cells of middle-aged adults; methylation in-
creased from pre- to post-stress and decreased from post-stress to
follow-up. Whether these changes reﬂect responses to stress-related
changes in oxytocin or are regulated by other pathways, such as changes
in the HPA axis, remains to be studied.
The long-term effect of the exposure to drugs of abuse and alcohol
is not clear yet. Oxytocin seems to be released in response after acute
exposure to, for example, MDMA (ecstasy) and methamphetamine, as
shown in human (Dumont et al., 2009; Wolff et al., 2006) and animal
studies (Broadbear et al., 2011; Thompson et al., 2007). This could
imply a role for oxytocin in some of the drug effects that are experi-
enced. On the other hand, McGregor and Bowen (2012) shows that
chronic drug use (e.g. cocaine, morphine and cannabis) and alcohol ex-
posure decreases brain OXT synthesis in the rat. His group also did not
show a signiﬁcant difference in basal oxytocin (or vasopressin levels)
in a group of current methamphetamine users meeting DSM IV criteria
for dependence. However, these patients were not in a drug-free state
(Carson et al., 2012).
5.3. Possible outcome of altered oxytocin levels and signalling
The long-term effect of social inﬂuences on brain structure and func-
tion including positive social experiences or adversitymay be capable of
affecting brain plasticity (Davidson and McEwen, 2012). The function-
ing of the oxytocin system seems to be sensitive to external inﬂuences
such as epigenetic events and neuroplasticity (Macdonald, 2012;
Meaney, 2001). Research shows that levels of oxytocin in the body
differ depending on previous experiences, including endocrine expe-
riences (Carter et al., 2009) and acute challenges (Ebstein et al., 2012;
Feldman et al., 2010b; Grippo et al., 2009).
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during development in rats, data reports lower blood pressure (Holst
et al., 2002), lower corticosterone levels (Sohlström et al., 2000), higher
body weight (Sohlström et al., 2000), and oxytocin administration can
reverse the effects of maternal malnutrition (Olausson et al., 2003).
Importantly, a study by Bowen et al. (2011) demonstrated oxytocin
administration during puberty included reduced alcohol drinking in
adulthood.
Bales et al. (Bales et al., 2007) speciﬁcally investigated the long-
term effects of increased oxytocin exposure in prairie voles, versus
an oxytocin antagonist, or vehicle, on postnatal day 1. No signiﬁ-
cant treatment difference was observed for OXTR binding, however
effects on the V1a receptor were found (some of which were gender
speciﬁc).
Andersen (2003) reviewed the trajectories of brain development
and discussed the windows in time during which brain development
is most plastic, including age-related changes in neuron development
and pruning,myelination, receptor and synapse andmigration. Although
oxytocin was not a speciﬁc focus of that paper, it is useful to note that
developmental periods when the environment and epigenetics can
have the strongest impact (for example, during gestation, after birth
and in adolescence), are periods when it is likely that oxytocin is either
elevated or otherwise in ﬂux.
Inﬂuences during early development might affect migration and
survival of neurons, which might strongly affect interactions be-
tween oxytocin and other neuromodulatory systems (as discussed
in Section 6).
Prospective longitudinal studies are currently conﬁrming that there
are clear vulnerable periods. For example, Bosch and Neumann (2012)
showed increased cortisol levels in teenagers who experienced prenatal
stress, or those who experienced a combination of pre/postnatal adver-
sity and adversity between age 6 and 11 (but not those with adversity
between 0 and 5 only).
The previous section describes the individual differences that have
been reported in the endogenous oxytocin, and the causes of these dif-
ferences. The next paragraph will look at how oxytocin in general, and
these individual differences in endogenous oxytocin, can affect suscep-
tibility to addiction.Table 1
Overview of studies on individual differences in the endogenous oxytocin system. Outcomes are
rodent studies.
Factors Outcome
Individual factors
Species
Section 5.1
Distributions of OXTR differ between species
Gender
Section 5.1.1
Sex steroids affect OXT synthesis and receptors
OXTR expression is affected by oestrogen
Oxytocin responses to stress sex dimorphic
Effect of prenatal stress and early life stress on the OXTR sex dimo
Effect steroid hormones and OXTR binding discussed
Genetic differences
Section 5.1.2
Structural and functional alterations in brain of OXTR risk allele (r
OXT gene polymorphisms (rs4813625) inﬂuences dopamine func
OXTR polymorphisms (rs4564970 and rs1488467) moderate alco
aggressive behaviour in adult men
Williams Syndrome: overproduction of oxytocin in response to sp
OXT levels reduced in children with autism
Age
Section 5.1.3
Development OXT system starts in utero and continues into adole
OXTR in the rat brain present during entire development; prairie
transient expression and reorganisation
OXTR density, but not receptor afﬁnity changes in development
Life phase
Section 5.2.5
Lactation and parturition induce changes in synaptic and extrasyn
of oxytocin neurons in the SON of the hypothalamus
Dendritic remodelling of OXT neurons in the hypothalamic ventro
happens during the female cycle6. Oxytocin and addiction
Studies focused on the role of oxytocin on drug effects and addiction
began to emerge in the early 1980s (for overview see Sarnyai and
Kovacs, this issue). However, as more data on the functions of oxytocin
has become available, theories and data on the role of oxytocin in addic-
tion have begun to receive attention. New techniques and advances in
research on the role of oxytocin in social rewards and on oxytocin as a
treatment have put new life into the area.
Recent studies are also showing that oxytocin is released in response
to, for example, acute MDMA (ecstasy) and methamphetamine admin-
istration both from human (Dumont et al., 2009; Wolff et al., 2006) and
animal studies (Broadbear et al., 2011; Thompson et al., 2007). This
could imply a role for oxytocin in some of the drug effects that are
experienced.
In recent years, a large number of papers have reported oxytocin's
direct and indirect effect on processes and behaviours linked to addic-
tion, although few have looked at the role of individual differences in
the endogenous oxytocin system on addiction directly. To examine the
possible role of individual differences in the oxytocin system on addic-
tion, this section will ﬁrstly describe the effects of oxytocin administra-
tion on drug use behaviour and secondly examine the neurobiological
interactions that are at the basis of some of oxytocin's indirect effects
on addictive behaviour. Table 1 provides an overview of the studies list-
ing individual differences in the endogenous oxytocin system affecting
alcohol and drug use; Table 2 provides an overview of the environmen-
tal factors reported to affect oxytocin in different life phases. It is postu-
lated that differences in the endogenous oxytocin systemwill be able to
affect both the initial response to drugs, and the chance addiction will
develop (Section 7).6.1. Direct effects of oxytocin on drug-taking behaviour and addiction
Over the years several effects of oxytocin on drug taking behaviour
were demonstrated showing effects on various phases of drug use.
Kovacs showed early on that centrally acting oxytocin inhibited the
development of tolerance to morphine, and decreased the symptomsdescribed in detail in the text in designated sections. Note: animal studiesmainly relate to
Reference Human/animal
Shapiro and Insel (1989),
Witt et al. (1992)
H/A
Gimpl and Fahrenholz (2001) A
Young et al. (1997) A
Bales et al. (2011) A
rphic Carter et al. (2009) A
Opacka-Juffry and Mohiyeddini (2012) H
s53576) carriers Tost et al. (2010) H
tion Love et al. (2012) H
hol induced Johansson et al. (2012a, 2012b). H
eciﬁc stimuli Dai et al. (2012) H
Hollander et al. (2003) H
scence Nylander and Roman (2012),
Bales and Perkeybile (2012)
H/A
voles show Bales and Perkeybile (2012) A
Bales and Perkeybile (2012) A
aptic transmission Oliet and Bonfardin (2010) A
medial nucleus Ferri and Flanagan-Cato (2012) A
Table 2
Overview of studies on environmental factors affecting in the endogenous oxytocin system in each life phase. Outcomes are described in detail in the text in designated sections. Note:
animal studies mainly relate to rodent studies.
Factors Outcome Reference Human/animal
Gestation
Section 5.2.1
Prenatal stress Unpredictable stressors during last week of gestation resulted in reduced levels of OXT mRNA in the PVN
and increased OXTR binding in the central amygdala in male rats
Lee et al. (2007) A
Restraint stress of dams in last week of gestation (plus parenting by these dams) caused decreased number
of OXT-positive magnocellular neurons in male offspring
De Souza et al. (2013) A
Prenatal drug
exposure
Gestational cocaine exposure causes long-termdecreases in OXT levels in hippocampus, hypothalamus and
preoptic area
Johns et al. (1998) A
Combination of prenatal alcohol and nicotine exposure caused increased OXTR binding in the NAcc and
hippocampus in adult males (not female)
Williams et al. (2009) A
Review: effect of prenatal cocaine exposure and maternal behaviour of cocaine-exposed dams on OXT
levels and OXTR in neonatal rat pups
Williams and Johns (2014) A
Infancy and early life
Section 5.2.2
Social experiences
and parenting
Infants exposed to high affect parent-infant synchrony had increased OXT saliva measures Feldman et al.
(2010a, 2010b)
H
Secure attachment and oxytocin affect cortical loops Tops et al. (2014-in this issue) H
Children raised in institutions in Romania before adoption showed altered oxytocin reactivity years later Wismer Fries et al. (2005) H
Early parental separation was associated with decreased saliva cortisol excretion in response to intranasal
oxytocin in young males
Meinlschmidt and
Heim (2007)
H
Early life stress (assessed by questionnaire) linked to lower OXT levels in healthy adult males Opacka-Juffry and
Mohiyeddini (2012)
H
Review of early life manipulations on distribution and expression of OXTR Veenema (2012) A
Altered levels of OXT after early-life stress in speciﬁc brain regions (e.g. hypothalamus, pituitary and
amygdala)
Oreland et al. (2010) A
Maternal separation caused robust age-related changes in OXTR binding in several brain regions Lukas et al. (2010) A
Parenting conditions in rats affected OT content in a sex dependent manner Ahern and Young (2009) A
Maternal stimulation (grooming) appeared to affect oxytocin receptor gene expression Champagne (2008) A
Childhood
Section 5.2.3
Stress Basal blood levels of OXT were reduced after childhood (but not adolescent) stress in adult healthy males Opacka-Juffry and
Mohiyeddini (2012)
H
Trauma Lower OXT basal levels in the CSF of women who experienced child abuse (emotional abuse strongest) Heim et al. (2009) H
Social environment Enhanced oxytocin receptor levels in selected nuclei of the amygdala after high peer-interactions Branchi et al. (2012) A
Illness Reactivity of OXT systemwas changed after Trier social stress test in childhood cancer survivors compared
to controls and people who had been sexually abused
Pierrehumbert et al. (2010) H
Adolescence/Adulthood
Sections 5.2.4 & 5.2.5
Stress Psychosocial stress exposure might dynamically regulate OXTR promoter methylation Kumsta et al. (2013) H
Experimental psychological stress can induce transient alterations in methylation of the OXTR on mono-
nuclear blood cells
Unternaehrer et al. (2012) H
Drugs of abuse Acute exposure to e.g. MDMA and methamphetamine cause OXT release H: Dumont et al. (2009),
Wolff et al. (2006),
A: Broadbear et al. (2011),
Thompson et al. (2007)
H/A
Chronic drug use (e.g. cocaine, morphine and cannabis) and alcohol exposure decreases brain OXT synthesis McGregor and Bowen (2012) A
No signiﬁcant difference in basal oxytocin levels in a group of currentmethamphetamine users; note: users
were not drug-free
Carson et al. (2012) H
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heroin in rats (Ibragimov et al., 1987; Kovács et al., 1985, 1998).
Central oxytocin injections in animals were effective in modulating
other drug-related behaviours. Intracerebroventricular (ICV) oxytocin
inhibited methamphetamine-induced conditioned place preference
(CPP), facilitated the extinction of methamphetamine-induced CPP
and prevented its stress-induced reinstatement in mice (Qi et al.,
2009). Additionally, microinjections of oxytocin directly into the NAcc
core reduced the CPP produced bymethamphetamine (as did injections
into subthalamic nucleus), and inhibited cocaine-induced stereotyped
behaviour in rats. (Baracz and Cornish, 2012; Sarnyai et al., 1991).
Oxytocin was found to dose-dependently decrease cocaine-induced
hyperlocomotion, and stereotyped grooming behaviour (Kovács et al.,
1998).
Systemic administration of oxytocin was shown to have intrinsic
reinforcing properties, and was able to affect drug-taking behaviour of
drugs of abuse.Liberzon et al. (1997) showed that oxytocin (subcutaneously 6 m/kg)
itself could induce conditioned place preference and therefore has
some motivational properties. Systemic administration of oxytocin
reduced intravenous methamphetamine self-administration in rats
(at 0.3–1 mg/kg i.p.; Carson et al., 2010a) and methamphetamine
CPP rats (Baracz and Cornish, 2012). Oxytocin also diminished the
capacity of non-contingent methamphetamine “primes” to reinstate
methamphetamine-seeking behaviour in abstinent rats (Carson et al.,
2010a). Oxytocin administration during adolescents (1 mg/kg i.p. PND
33–42) reduced alcohol consumption in adult rats (Bowen et al., 2011).
Looking at the underlying mechanisms behind these effects, Carson
et al. (2010b) demonstrated that systemic oxytocin signiﬁcantly re-
duced methamphetamine-induced neuronal activation in the NAcc
core, and the subthalamic nucleus using Fos immunohistochemistry.
Interestingly, systemic oxytocin injections (2 mg/kg) strongly acti-
vated oxytocin-positive cells in the supraoptic nucleus (Carson et al.,
2010a), supporting the hypothesis of a feed-forward effect of oxytocin
Fig. 2. Bi-directional interactions between oxytocin and key systems implicated in addic-
tion. Oxytocin has bidirectional interactions with several systems linked to direct drug
effects and increased susceptibility to addiction. Fig. 2A shows several key interactions
in an individual with an oxytocin system that has developed fully. Arrows show the
type of interaction (blue for an interaction; red for inhibitory, green for stimulation).
This graph is a simpliﬁed representation of the situation since more interactions exist
and the systems also interact with each other. Fig. 2B shows the suggested situation
after suboptimal development of the oxytocin system due to early adversity. Each of the
systems will be affected by early adversity (red and light blue boxes). Additionally, the
modulatory role of oxytocin on the other systems is reduced (dashed lines). It is proposed
that oxytocin levels and reactivity will be reduced and that the negative feedback loops
that would normally exist might not work optimally. The suggested outcome is an in-
creased susceptibility to addiction.
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2008). Carson also hypothesized that there was a long-lasting up-
regulation of endogenous oxytocinergic systems after repeated systemic
oxytocin treatment to rats self-administering methamphetamine, since
this resulted in chronically increased plasma levels of oxytocin (Carson
et al., 2010a).
This overview suggests that oxytocin administered both centrally or
in the peripherally can attenuate drug-taking behaviour in different
phases of drug use.
6.2. Indirect effects of oxytocin on key systems involved in addiction
Mounting evidence demonstrates that neurobiological systems im-
plicated in addiction processes (Section 3) interact with the oxytocin
system. This section will explore the hypothesis that the endogenous
oxytocin system is able to modulate drug taking and susceptibility to
addiction via its effect on key biological systems such as themesolimbic
dopamine system, HPA-axis and immune system. (Several other inter-
actions might be very important, but examining this is beyond the
scope of this paper.) It is postulated that an underdeveloped oxytocin
system is unable to modulate behaviour in a way that reduces, for ex-
ample, the rewarding properties of drugs- and stress-induced relapse.
Fig. 2A shows the bidirectional interactions of oxytocinwith key sys-
tems implicated in addiction focussing on neurotransmitter systems
(e.g. dopamine and serotonin), the HPA-axis, the Vagal Nerve and glia.
The feedback and feed-forward loops are suggested to ﬁne tune the
body's response to external challenges. Fig. 2B illustrates the situation
in adults after a less optimal development of the bidirectional interac-
tions with oxytocin system. The oxytocin system is not as able to damp-
en the response to stressors and drugs of abuse, leaving the body more
prone to develop maladaptive behaviour such as excessive alcohol and
drug use. The following sections will discuss these interactions and
the effect of environment on them in detail.
6.2.1. Oxytocin interactions with the mesolimbic dopamine system
Nearly all drugs of abuse increase dopamine in themesolimbic dopa-
mine system, either directly or indirectly (Pierce andKumaresan, 2006).
Thomas Insel and others have commented on the fact that the dopa-
mine reward pathway seems to be involved in parenting and social
reward (Insel, 2003) and have speculated on the shared neurobiological
basis with addiction. Recent studies show that the oxytocin and dopa-
mine systems interact to affect the rewarding value of social stimuli
(Champagne et al., 2004; Shahrokh et al. (2010) and drug reward
(Young et al., 2008, 2011). This interaction has been demonstrated in,
for example, the VTA and NAcc, and research is now focusing on the
PFC. An interaction between the dopamine and oxytocin system could
be a driving force behind the balance between social and drugs reward.
Two recent papers by Tops et al. (2013, 2014-in this issue) explore
experience-dependent plasticity, where the parent's behaviour affects
the brain development of the child. We postulate that attachment
and oxytocin affect engagement of corticostriatal loops, thus affecting
the balance between the search for immediate reward and familiarity
(Tops et al., 2013, 2014-in this issue).
Several studies using prairie voles have illustrated the link between
oxytocin and dopamine involvement in the regulation of social behav-
iour, and in the effects of exposure to parental behaviour. Shahrokh
et al. (2010) have provided comprehensive novel evidence for a direct
effect of oxytocin at the level of the VTA in the regulation of NAcc dopa-
mine levels from studies ofmaternal behaviour in lactating rats. Individ-
ual differences in maternal care (e.g. licking and grooming) can be
regulated either with oxytocin antagonists, or treatments that eliminate
differences in the NAcc dopamine signal.
Direct infusion of oxytocin into the VTA increased the dopamine
signal in the NAcc (Shahrokh et al., 2010). High LG compared with
low LG mothers showed greater increases in dopamine signal in the
NAcc during bouts of pup LG. Importantly, this difference was abolishedafter infusion of an oxytocin receptor antagonist directly into the VTA
(Shahrokh et al., 2010).
Interestingly, Young et al. (2008, 2011) provided further evidence
demonstrating the interactions between the oxytocin and dopamine
system in both social and drug reward in prairie voles: methamphet-
amine was shown to reduce pair bonding and pair bonding was able
to reduce the rewarding properties of methamphetamine in prairie
voles. The mesolimbic dopamine pathway and oxytocin were the key
regulators of this behaviour, interacting in the NAcc. They showed that
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interaction, and that social interaction could reduce the reward from
drugs. Unpublished data byWang also demonstrated that prefrontal oxy-
tocin mediates drug and social reward interaction. Local administration
of oxytocin in this area can restore drug-induced alterations in pair
bonding.
These data from animal studies show that the dopamine and oxyto-
cin system are not just co-localised, or have a unidirectional effect, but
rather the interactions among oxytocin and dopamine are bidirectional.
Fromother basic researchwe also know that oxytocin acts on oxyto-
cin receptors in themedial preoptic area resulting in an increased dopa-
mine release in the VTA (Champagne et al., 2004; Shahrokh et al., 2010).
Infusing an oxytocin receptor antagonist in the VTA diminishes this ef-
fect completely (Shahrokh et al., 2010) and even results in a functional
normalisation of maternal behaviour in female rats that naturally show
reduced levels of pup LG (Champagne et al., 2004).
The existence of a dopamine-oxytocin interaction may not be sur-
prising, since early studies by Kovacs et al. (for a review see Sarnyai
and Kovacs, this issue) showed that the rewarding effect of drugs like
methamphetamine and cocaine could be modulated using oxytocin.
The newstudies however demonstrate thedirect functional bidirection-
al interaction between the dopamine and oxytocin system and the ef-
fects this interaction has on social and drug-taking behaviour.
However, we know that the oxytocin system shows large inter-
species differences, so the next questionwould be: does this interaction
also exist in humans as well. Interestingly, Love et al. (2012) have re-
cently shown that oxytocin gene polymorphisms in humans inﬂuence
dopamine function in a gender-speciﬁc manner.
6.2.2. Interactions with the HPA-axis
Oxytocin has a bidirectional interactionwith theHPA-axis. Stressors,
such as a Trier social stress task, can induce changes in oxytocin levels
in humans (Pierrehumbert et al., 2010). Additionally, oxytocin tends
to reduce ACTH secretion from the anterior pituitary (Opacka-Juffry
and Mohiyeddini, 2012) as reported in humans, and may tonically in-
hibit CRF, and, consequently, corticosterone secretion in virgin female
rats (Neumann et al., 2000).
CRF is distributed throughout the brain but particularly high con-
centrations of cell bodies are found in the PVN of the hypothalamus.
Dabrowska et al. (2011) provided neuroanatomical evidence in rats
for a possible reciprocal regulation of the CRF family of peptides, as
well as oxytocin systems in the hypothalamus and the BNST. CRFR2
located on oxytocinergic neurons and axon terminals might regulate
the release of this neuropeptide and OXTR activation might regulate
excitability of CRF neurons in the PVN. This might be a crucial part of
potential feedback loop between the hypothalamic oxytocin system
and the forebrain CRF system that could signiﬁcantly impact affective
and social behaviours, in particular during times of stress.
Koob (Koob, 2008; Koob and Volkow, 2009) reviews evidence dem-
onstrating a strong role for CRF in addiction, including in the transition
to dependence and themaintenance of dependence. Oxytocin canmod-
ulate responsiveness of the HPA axis (Baskerville and Douglas, 2010;
Parker et al., 2005). At a behavioural level: oxytocin can protect against
some of the effects of social stress and isolation in animals (Parker et al.,
2005). Thus, oxytocin may be perceived as a common regulatory ele-
ment of the social environment, stress response, and stress-induced
risks on mental and physical health (Smith and Wang, 2012).
6.2.3. Interactions with serotonin
Serotonin and its interaction with oxytocin seem to be important in
speciﬁc drug effects, such as seen after MDMA use in animals and
humans. This is the primary focus of a different review paper in this
issue (Broadbear et al., 2011; 2013). Importantly, Eaton et al. (2012)
demonstrated that oxytocin has site-speciﬁc organisational inﬂuence
on the serotonin system during the neonatal period. For example ago-
nist treatment on PND 1 affected serotonin axon length density onPND 21 in regions of the hypothalamus (but not PVN) and amygdala.
These effects for example modulated social behaviour in prairie voles.
It is not clear whether these inﬂuences have functional outcomes on
addiction-related behaviours.6.2.4. Interactions with glia and the peripheral immune system
A primed immune system seems to increase the susceptibility to de-
velop addiction as well as other mental health problems (Frank et al.,
2011). Several triggers can cause this primed state to develop (for ex-
ample, trauma and illness).
Oxytocin seems to interact with the peripheral immune system,
where oxytocin has an anti-inﬂammatory effect (Gutkowska and
Jankowski, 2012). Interestingly Clodi et al. (2008) demonstrated that
exogenous oxytocin could reduce the neuroendocrine and cytokine re-
sponse to bacterial endotoxin in healthy men.
The interaction between oxytocin and glia is also of interest in the
suggested tripartide synapse. The PVN of the hypothalamus acts as
an integrative centre (Yang et al., 1997): in this area glia are able
to modulate glutamate/GABA and oxytocin neurotransmission in
an environment-dependent manner. Oxytocin neurons in the PVN
(and SON) are surrounded by glia in a dynamic interaction in a
tripartide synapse (Theodosis et al., 2008). This allows not only
rapid adjustment to the changing environment (for example, stress)
but also to longer term changes, such as during pregnancy. Oliet et al.
(2008) showed how glial processes change shape, by protruding and
becoming a barrier that limits diffusion of neurotransmitters, or
alternatively retracting to allow the release of neurotransmitters.
This structural change directly affects glutamate and GABA neuro-
transmission, as well as neurotransmission in the oxytocin neurons.
Additionally, changes in the glutamate system are often reported after,
for example, maternal separation and have been linked to changes in
the psychological aspects of drug-taking behaviour. A recent review
also demonstrates important interactions among dopamine, glutamate
and oxytocin (Yang et al., 2010).6.2.5. Interactions with the vagus nerve
The autonomic nervous system helps to regulate the emotional and
subjective experiences that are associated with addiction. The parasym-
pathetic or vagal branch of the autonomic nervous system is of particular
importance to the capacity to modulate over-reactivity to challenges, in-
cluding those associated with addiction and withdrawal. The brainstem
regions that regulate the efferent vagus can be divided into two phyloge-
netically and anatomically distinct systems. The older unmyelinated
vagal pathways originate in the dorsal motor complex, while the more
recent myelinated ﬁbres (primarily found in mammals) can be traced
to the ventral vagal complex (Porges, 2007). Myelinated vagal pathways
constitute the social engagement system, which coordinates autonomic
activities need to support social communication and emotional regula-
tion. Research directly examining the role of the parasympathetic pro-
cesses in addiction is comparatively rare. However, as one example, Liu
et al. (2011) recently showed that vagal nerve stimulation can inhibit
heroin- or heroin cue-induced relapse in rats, in part by regulation of
the nucleus accumbens. Indirect evidence for a role for the vagus in
addiction comes from mounting evidence for a role for the vagus in the
regulation of social behaviour (Porges, 2007).
Both social behaviour and activity of the vagus can bemodulated by
oxytocin (Carter et al., 2009). In addition, the visceral tissues that are
outside of the blood brain barrier (including the vagus nerve) contain
oxytocin receptors, (Welch et al., 2009). Thus, the effects of oxytocin
may be readily and quickly transmitted to the central nervous system
via the vagus nerve. The sensitivity of the autonomic nervous system
to the regulatory effects of oxytocin may help to explain recent data
implicating oxytocin in the vulnerability to addiction and the capacity
to manage the symptoms of withdrawal (Pedersen et al., 2012).
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The interactions described above are believed to take place pri-
marily in the hypothalamus and in areas important in the
mesolimbic dopamine system (such as VTA, NAcc and PFC) as well
as in the periphery. The hypothalamus is an interesting area as it is
a meeting place for several important regulatory systems including
oxytocin, serotonin and GABA/glutamate neurons, HPA-axis, infor-
mation from the spinal cord, and the immune system (Eaton et al.,
2012; Oliet et al., 2008; Yang et al., 1997). These interconnections
could be key in modulating our vulnerability to develop neuropsy-
chiatric disorders and addiction. Several studies have shown long-
term, experienced-based changes to the HPA axis and hypothalamus
(Davidson and McEwen, 2012).
7. Summary of the suggested model
The oxytocin system changes and matures over time as part of
normal development (Section 5.1.3). This paper postulates that
early external inﬂuences (like stress, social adversity and infec-
tion) affect the developing endogenous oxytocin system, changing
receptors, hardware and set points. This results in individual differ-
ences in oxytocin levels, and altered responsiveness of the oxytocin
system. This disturbed development can lead to increased suscep-
tibility to the development of addiction, and reduced resilience to
stress.
Early inﬂuences also affect the other systems that the oxytocin
system interacts with, such as neurotransmitter systems (like
dopamine, serotonin, glutamate and GABA), the immune system, and
the stress axis (Fig. 2). Speciﬁc sensitive periods exist for all these sys-
tems where external inﬂuences can have long-lasting effects, for exam-
ple during gestation and after birth, but also during adolescence.
Individuals may show only minor differences in behaviour and function
unless subsequent stressors, infection, or drug use, challenges the system
again. This is when the increased susceptibility to addiction becomes
apparent. Since these systems are all inter-dependent and regulate
each other, early life adversity can change the balance of this entire sys-
tem and minimise the negative feedback loops that would normally
exist.
It is postulated that early adversity can disrupt the normal devel-
opment of the oxytocin system and other systems, leading to a less
ﬁne-tuned system. A well-developed oxytocin system is in a posi-
tion to directly and indirectly increase resilience, for example by re-
ducing drug reward, increasing social reward, reducing anxiety,
reducing stress response and immune stimulation. A well-
developed system that is able to respond in times of stress, as well
as social support, may decrease the chance that someone escalates
their use and relapses when they have attempted to quit. If adversi-
ty is encountered, the oxytocin system still develops, but basal
levels might be lower and it might be less responsive. Connectivity
might be different with other systems. In short, individual differ-
ences in the endogenous oxytocin system may arise based on early
life experiences.
8. Discussion: limitations and considerations
Here we propose a framework, focused on contemporary
knowledge of oxytocin, for future research on drug addiction.
Our goal is to generate hypotheses on the role of the endogenous
oxytocin system in addiction. There is at present no direct evi-
dence of the role of the endogenous oxytocin in addiction in
humans. However, research in this area is progressing rapidly.
The following considerations and limitations are important around
this theory.
The paper has not focussed extensively on examining the role of
prenatal drug use on the oxytocin system or subsequent drug use.The pharmacological effects of drugs of course add further complexity
to our framework. However, a review byWilliams and Johns (2014) ex-
plores this relationship in detail.
Studying the neurobiology of addiction involves many inter-
dependent systems. This makes it hard to comprehend the effect
of a change in the oxytocin system and pinpointing whether it
leads to functional changes. Compensation by other systems is al-
ways a possibility. Additionally, changes as a result of early adver-
sity are not exclusive to addiction. The systems that are affected
by an altered oxytocin system have functions in many other
tasks such as learning and memory, mood, pain, social behaviour
and so forth (Carter et al., 2009; Opacka-Juffry and Mohiyeddini,
2012).
Sex-dependent differences have been reported in the oxytocin
system, and the effect of stress on the oxytocin system (Section 5.1.1)
However, most preclinical addiction studies use males. The gender
differences in the endogenous oxytocin system in males and females
might warrant a more comprehensive approach. Especially since
humans also show a gender difference in problematic drug use, which
varies across different phases of addiction (Becker and Hu, 2008).
Females begin regularly self-administering licit and illicit drugs of
abuse at lower doses than do males, but use escalates more rapidly to
addiction. Additionally, females are at greater risk for relapse following
abstinence (for a review see Becker and Hu, 2008). It might be that the
oxytocin system has a stronger inﬂuence on drug-taking behaviour in
women.
While describing the effects of oxytocin on addiction, vasopressin
has been partly disregarded. However, oxytocin and vasopressin
show cross reactivity and both are altered after, for example, mater-
nal separation (Carter et al., 2009; Lukas et al., 2010). Early studies
examined both the effects of oxytocin and vasopressin on behaviour,
with these neuropeptides showing opposing effects on tolerance and
withdrawal of, for example, ethanol, heroin and cocaine (Sarnyai,
1998; Sarnyai et al., 1992; Szabó et al., 1987, 1988). However, most
recent studies only focus on one of the two peptides. Edwards
(Edwards et al., 2012) has suggested vasopressin may be important
in addiction through its affects on the brain stress-system. This
recent study demonstrated the role of vasopressin AVPRV1b recep-
tors in mediating the transition to excessive drinking in ethanol-
dependent rats. Early life stress might cause changes in the vasopres-
sin system of men, with most research focusing on AVPRV1b
receptor.
Oxytocin seems to increase sensitivity to social cues (Guastella
et al., 2012). A strong social network and strong relations have
been known to delay initiation of drug use and have a positive effect
on treatment outcome when dependence has developed. Adoles-
cence is characterised by an increased sensitivity to peers and social
pressure and peer pressure or encouragement can contribute to drug
use, whether positive or negative, with effects that are most appar-
ent for the initiation of use (Mundt, 2011). Increased oxytocin levels
might further increase the rewarding value that is received from so-
cial interactions and may make young people very sensitive to peer
pressure. Peer culture around low or moderate use can be protective
against excessive use; however this is not commonplace in all
cultures.
Lastly, this theory might seem to imply that having more oxyto-
cin is regarded as optimal. However, genetic disorders like Williams
Syndrome show that high levels of oxytocin do not necessarily pro-
mote optimal behavioural responses (Dai et al., 2012). As another
example, an exaggerated oxytocin release in response to stress (or
cortisol administration) may be maladaptive or indicative of a par-
ticularly intense form of stress (Pierrehumbert et al., 2010). A
well-regulated system with well functioning feedback loops is like-
ly to be ideal. However, circumstances that block these natural sys-
tems from developing normally tend to disrupt natural feedback
systems, creating complex disorders with negative behavioural
35F.T.A. Buisman-Pijlman et al. / Pharmacology, Biochemistry and Behavior 119 (2014) 22–38and physiological consequences. Understanding the role of individ-
ual differences in alcohol and drug use and the development of de-
pendence can open new opportunities for the development of valid
therapeutic approaches to drug addiction.
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